Rachel Langland

Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAF^<i>V600E</i> mutation

Jeanne Tie, Peter Gibbs, Lara Lipton et al. · International Journal of Cancer · 2010 · 226 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Analytical Performance of a Real-time PCR-based Assay for V600 Mutations in the BRAF Gene, Used as the Companion Diagnostic Test for the Novel BRAF Inhibitor Vemurafenib in Metastatic Melanoma

Harkanwal Halait, Kelli DeMartin, Sweta Shah et al. · Diagnostic Molecular Pathology · 2012 · 145 citations

Medicine, Molecular Biology, Oncology +17

Multisite Analytic Performance Studies of a Real-Time Polymerase Chain Reaction Assay for the Detection of BRAF V600E Mutations in Formalin-Fixed, Paraffin-Embedded Tissue Specimens of Malignant Melanoma

Steven M. Anderson, Kenneth J. Bloom, Dino U. Vallera et al. · Archives of Pathology & Laboratory Medicine · 2012 · 138 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results

Eriene Youssef, Elizabeth Berry‐Kravis, Christian Czech et al. · Neuropsychopharmacology · 2017 · 127 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Repression of organizer genes in dorsal and ventral<i>Xenopus</i>cells mediated by maternal XTcf3

Douglas W. Houston, Matthew Kofron, Ernesto Resnik et al. · Development · 2002 · 105 citations

Life Sciences, Developmental Biology, Molecular Biology +17